Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomesM. Iborra,B. Caballol, A. Garrido,J. M. Huguet,F. Mesonero,A. Ponferrada, L. Arias-Garcia,M. M. Bosca-Watts, S. J. Fernandez-Prada, E. Brunet-Mas, A. Gutierrez-Casbas,I. Ordas, L. Ruiz,I. Garcia de la Filia, J. Escobar Ortiz,B. Sicilia,E. Ricart,P. NosJOURNAL OF CROHNS & COLITIS（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
